Epilepsy has been recognized since the earliest medical writings and is one of the most commonly diagnosed neurological conditions. However, the epidemiology of epilepsy is still not fully understood due to its heterogeneous nature and complex etiologies. 1, 2 In addition, regional differences in the etiologies and epidimiological features of epilepsy have been widely reported in literature. 3, 4 Numerous studies have identified genetic risk factors for epilepsy. 5 Therefore, studies focusing on isolated geographic areas with unique genetic and environmental factors may be important for understanding the etiology and epidemiology of epilepsy.
Previous studies of epilepsy in China revealed regional differences in prevalence. For example, Li et al. reported a 4.4% lifetime prevalence of epilepsy in the urban areas of six cities in China. 6 Wang et al. reported a 7.04% lifetime prevalence of epilepsy in the rural areas of five provinces in China. Regional differences in the prevalence of active epilepsy have also been reported. For instance, the 5-year prevalence of active epilepsy is Purpose: To investigate the prevalence and clinical characteristics of active epilepsy in southern Han Chinese.
Method: A door-to-door survey about epilepsy was conducted in communities identified by random cluster sampling among 20 villages and 3 communities of Yueyang city. A questionnaire for epilepsy based on the World Health Organization screening questionnaire was used. A final diagnosis of epilepsy was made by neurology specialists with the support of head magnetic resonance imaging (MRI), computed tomography (CT), and electroencephalography (EEG) if available. The prevalence, clinical characteristics, and treatment gap were analyzed in patients with active epilepsy within the past year and the past 5 years. Results: Active epilepsy was identified in 91 patients within the past year and 117 patients within the past 5 years. The one-year prevalence was 2.8%, and the five-year prevalence was 3.7%. The prevalence for epilepsy active within the last year and the last five years was significantly higher in rural areas than in urban areas (P < 0.05). Secondary generalized tonic-clonic seizures (53.8%) were the most common seizure type in patients whose epilepsy had been active in the last year. 34.1% of patients were diagnosed with structural or metabolic epilepsy. The most common cause for epilepsy was cerebrovascular disease (32.3%), followed by traumatic brain injury (29.0%). The treatment gap was 93.4%.
Conclusion:
The prevalence of epilepsy active within the last one and five years was higher in rural areas than in urban areas of Yueyang city. A large treatment gap exists in this area and a rational intervention strategy is needed. ß 2014 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved. 
Materials and methods

Population
Yueyang city has jurisdiction over three districts and six counties with a total population of 5.5 million. Random cluster sampling was performed at 23 survey points and 4 survey units in 20 villages and 3 communities. These villages and communities were selected because all residents are Han Chinese. The inclusion criterion was that residents must be currently living in the surveyed area with household registration and have temporarily left the area for no more than 1 month.
Epidemiological survey
This study was approved by the Human Research Committee of Yueyang City and Xiangya Hospital. The committees check studies for both scientific content and potential ethical issues. Written informed consent forms were obtained from all participants or their guardians. This study was conducted in two stages in accordance with the Declaration of Helsinki. In the first stage, welltrained local healthcare workers conducted a door-to-door screening of all residents. The questionnaire is a standard questionnaire for epidemiological studies of epilepsy developed from the WHO (World Health Organization) screening questionnaire that includes 13 questions. 11 When one or more positive signs of epilepsy were discovered, potential patients were further validated by interviewing the patient's family members and witnesses. In the second stage, patients were directly interviewed by experienced neurologists, and a final diagnosis of epilepsy was made with the support of available MRI, CT, or EEG data. Standardized treatments were given to patients who were diagnosed with epilepsy but did not previously receive standardized treatment. The standardized treatment was defined as treatment following the internationally accepted norms for the treatment of epilepsy. 12 All difficult-to-diagnose cases were discussed by experts from the Department of Neurology at Xiangya Hospital, Central South University.
Standard of diagnosis
Patients were recruited according to the ILAE recommended standard epilepsy diagnosis criteria. 13 In this study, epileptic seizures and etiology of seizures were defined according to the International League Against Epilepsy (ILAE) classification and Nomenclature Committee Report, 2005-2009. 14 A prevalent case of active epilepsy is defined as a person with epilepsy who had at least two epileptic seizures within the past year regardless of antiepileptic drug (AED) treatment. 15, 16 People who experienced at least two seizures in the past 5 years were also included in this study. The seizure frequency is divided into low, moderate, and high seizure frequency. 17 Treatment gap was defined as the percent of patients with active epilepsy that had not received optimal, regular AED treatment a week before the survey began. 15, 16 Regular AED treatment follows internationally accepted norms for the treatment of epilepsy. 12 
Data collection
The patients' gender, age, living area (rural or urban), onset age, frequency, and etiology of epilepsy, family history, and treatment information were collected. The total prevalence of active epilepsy was calculated by the number of cases that had 2 or more noninduced seizures per 1000 investigated individuals. The prevalence of active epilepsy for each variable or characteristic was the number of cases with active epilepsy per 1000 individuals with each variable or characteristic. The patient's data was included in the analysis only when: (1) the patient was Han Chinese with a clear family history indicating no marriage to ethnic minorities within the past 5 generations; (2) the patient had lived in southern China for over 3 generations. The patients with epilepsy that died were not included in this study because epilepsy is a clinical syndrome that is not commonly identified as a cause of death.
Statistical analysis
A database was established with EpiData 3.02 software, and data were analyzed using SPSS17.0 software. Two-sample x 2 test was used to compare the prevalence of active epilepsy between different genders and age groups.
Results
General characteristics of the population
A total of 32,059 people (52.9% male, 47.1% female) participated in the door-to-door surveys. 786 (2.45%) individuals had a history of seizures, and 143 (4.46%) individuals were clinically diagnosed with epilepsy. 91 (2.83%) patients were found to have active epilepsy within the past 1 year. 117 (3.65%) patients were identified to have active epilepsy within the last 5 years. Among the 91 patients diagnosed with epilepsy, 60 underwent head MRI/ CT scans (38 patients showed abnormalities), and 49 underwent electroencephalogram (EEG) examination (33 patients exhibited abnormal EEG). Table 1 shows the prevalence of active epilepsy within the past year in different genders, areas, and age groups. The prevalence of active epilepsy in the past year was 2.8%. The prevalence of active epilepsy was higher in males (3.12%) than in females (2.52%) but without significant difference (P > 0.05). The prevalence of active epilepsy was significantly higher in rural areas (3.7%) than in urban areas (2.0%) (P < 0.05). The prevalence of active epilepsy in different age groups was statistically significant (P < 0.05). The highest prevalence of active epilepsy was found in the 20-29 years old group (6.3%). 30 cases had an onset age before 9 years old (32.97%), 18 cases had an onset age between 10 and 19 years old (19.78%), and 17 cases had an onset age between 20 and 29 year old (18.68%). Table 2 shows the prevalence of active epilepsy within the past 5 years. The prevalence of active epilepsy in the past 5 years was 3.6%. The prevalence of active epilepsy was higher in males (4.1%) than in females (3.1%) but without significant difference (P > 0.05). The prevalence of active epilepsy was significantly higher in rural areas (4.9%) than in urban areas (2.4%) (P < 0.05). The prevalence of active epilepsy in different age groups showed no significant difference (P > 0.05). Table 3 shows the clinical characteristics of patients with active epilepsy in the past 1 year and the past 5 years. 91 patients had active epilepsy in the past 1 year. Among them, 34.1% of patients had a clear cause of structural or metabolic epilepsy with the most common cause being cerebrovascular disease (32.3%), followed by traumatic brain injury (29.0%), central nervous system infections (6.5%), brain tumors (9.6), cerebral hypoplasia (12.9%), neonatal intracranial hemorrhage (3.2%), and rodenticide poisoning (3.2%). Secondary generalized tonic-clonic seizures were the most common type of seizure (53.8%), followed by mixed seizures (35.2%), focal seizures with impairment of consciousness and awareness (7.7%), and focal seizures without impairment of consciousness and awareness (3.2%). Among the 91 patients with active epilepsy, 13, 28, and 50 cases (14.3%, 30.8%, 54.9%) had low, moderate, and high seizure frequency, respectively. 64.8% of the patients received nonstandard treatments and 29.7% did not receive any treatment. The treatment gap for patients with active epilepsy within the past year was 93.4%. 117 people had active epilepsy in the past 5 years with ages ranging from 1 to 87 years old (39.0 AE 21.4 years). The treatment gap for patients with active epilepsy within the past 5 years was 86.3%.
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Discussion
Despite the fact that epilepsy is one of the most common neurological diseases and has been studied for many decades, our understanding of its epidemiology is still deficient. This is partly because the etiology of epilepsy is complex, accurate diagnosis is difficult, and the heterogeneous nature of epilepsy has not been fully considered. In addition, most reports focus on the lifetime prevalence of epilepsy; whereas, there are relatively fewer reports examining the prevalence of active epilepsy. Thus, an epidemiological study of active epilepsy can provide more information for the prevention and treatment of epilepsy. In this study, we investigated the prevalence of active epilepsy in a geographic area of southern China using a sensitive screening survey and relatively accurate diagnostic approach.
Diagnostic accuracy and case ascertainment were thought to be major problems in the epidemiological study of epilepsy.
2 This is because a majority of patients with epilepsy do not exhibit permanent physical signs and can only be identified by looking through the patient's medical history. Therefore, diagnosis depends on the skill and experience of the diagnostician as well as the quality of witness information. Moreover, some patients with seizures may never seek medical care for a variety of reasons. This study was conducted in two stages. First, well-trained local healthcare workers conducted door-to-door screening using a standard questionnaire for epidemiological study of epilepsy. Individuals with one or more positive signs of epilepsy were further confirmed by a thorough interview with the patient's family members or witnesses. Second, potential patients were directly interviewed by experienced neurologists and examined in a clinic. Therefore, our study provides relatively accurate information on the diagnosis of epilepsy in patients. In addition, the etiologies and risk factors of epilepsy varies with geographic location. 3, 4 This suggests that genetic and environmental factors are important in the etiology of epilepsy. In this study, random cluster sampling was performed at 23 survey units in Yueyang city, an area with the lowest percentage of ethnic minority groups in China, and data from patients with a family history of marriage to ethnic minority groups were excluded from analysis. Therefore, the study population represents the typical southern Han Chinese population. In this study, 117 cases were diagnosed with active epilepsy within the past 5 years, of which 91 cases (78%) were diagnosed with active epilepsy within the past year; therefore, the majority of seizures occurred in the past year. The prevalence of active epilepsy was significantly higher in rural areas than in urban areas. The prevalence of active epilepsy in the past year and past 5 years in the rural areas of Yueyang city was lower than the reported prevalence in a study in rural areas of five provinces of China (Table 4) . 7 These differences may reflect the differences in geographical environment and genetic background between samples. Our study might best represent the southern Han Chinese population. In addition, Wang et al. study was conducted in 2002, 7 while our study was performed in 2010. During the past decade, socio-economic development brought great changes in the quality of medical care and education to patients in rural areas of China. The increased quality of medical care and education brought a decrease in the stigma associated with epilepsy and an increase in physician-patient confidentiality. Epilepsy is now starting to be recognized as a treatable ''disease'' and no longer as a case of supernatural possession in rural areas. This might also be a factor leading to the reduced prevalence of epilepsy observed in this study compared to previous studies. Although Hong Kong is also located in southern China, there are significant differences in the healthcare resources for patients with epilepsy between Hong Kong and Yueyang city. Patients in Hong Kong have access to better healthcare and better epidemiological report system. In addition, patients in the Hong Kong study were screened through phone calls although clinical follow up was used to confirm the results of their epidemiological survey of epilepsy (Table 4) . 8 When compared to studies in other resource-poor countries, the prevalence of active epilepsy in the past 5 years in the rural areas of Yueyang (4.9%) was higher than that in rural Tanzania 10 (2.9%) and rural Vietnam (4.4%). 9 However, the study in Tanzania was an adult-based survey of active epilepsy with a 9-month census survey conducted in 2009 (Table 4) . 10 The study lasted too long and is susceptible to the effects of floating population and disease factors, which may affect the prevalence rate. The study in rural Vietnam conducted in 2005 was based solely on residents over the age of 1 year and lasted for 11 months (Table 4) . 9 Besides the effects of a different sampling method and the lengthy study period, the diagnostic criteria were also different. Individuals with one epileptic seizure were included in Tuan et al. study, 9 whereas only individuals with at least 2 seizures were included in our study. The prevalence of epilepsy active within the past 5 years in population-based European studies in all ages varied from 3.3% to 7.8%. 2 Therefore, comparing the prevalence of epilepsy between studies in different countries is not likely to be helpful unless they used identical research approaches, similar diagnostic criteria, are located in similar geographic environments, and are clearly hypothesis driven. Although previous studies have described the distribution of seizure types in Asia, few studies are population-based studies. 18 In this study, secondary generalized tonic-clonic seizure (53.8%) was the most common type of seizure in patients with active epilepsy within the past year. There are very few studies that investigate the causes of epilepsy in Asian populations. Our study demonstrated that 34.1% of patients had a clear cause of structural or metabolic epilepsy. The most common cause was cerebrovascular disease (32.3%), followed by traumatic brain injury (29.0%). Previous reports on the etiologies and risk factors of epilepsy are highly divergent in regards to age and geographic location. 19 However, successful detection of risk factors depends on the extent of the investigation. Therefore, comparison of the results between studies is often problematic due to the differences in research methods and diagnostic accuracy.
The epilepsy treatment gap has been proposed as a useful parameter to compare quality of care for epilepsy patients across populations. 20 In this study, the treatment gap was defined as the percent of patients with active epilepsy that did not receive regular AED treatment a week before the survey began. The duration of 1 week was used in reference to a previous study in Chinese 7 to make comparing the two studies easier. In this study, only 6.6% of patients with active epilepsy took anti-epileptic drugs one week before the investigation. The treatment gap for patients with active epilepsy within the past year was 93.4%, which is higher than the treatment gap identified in a previous report. 7 The geographic environment, lack of neurology specialists, and a general lack of knowledge about epilepsy medication in this area may be responsible for the high treatment gap. Indeed, Wang et al. study in rural areas of five provinces in China 21 demonstrated that the treatment gap for active epilepsy can be decreased by 12.8% through the implementation of an epilepsy community control program.
In conclusion, the prevalence of epilepsy active within the past year and past 5 years is higher in rural areas than in urban areas of Yueyang city, which represents the prevalence of active epilepsy in southern Han Chinese. A large treatment gap suggests the need for a reasonable intervention strategy.
